The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Quidel Corp

Nasdaq: QDEL
Last

(U.S.) $27.01

Today's change-0.14 -0.52%
Updated March 30 11:53 AM EDT. Delayed by at least 15 minutes.
 

Quidel Corp

Nasdaq: QDEL
Last

(U.S.) $27.01

Today's change-0.14 -0.52%
Updated March 30 11:53 AM EDT. Delayed by at least 15 minutes.

Quidel Corp down (U.S.)$0.14

Quidel Corp is lower today, dropping (U.S.)$0.14 or 0.52% to (U.S.)$27.01. Over the last five days, shares have gained 3.01%, but are down 6.60% for the last year to date. Shares have underperformed the S&P 500 by 13.55% during the last year.

Key company metrics

  • Open(U.S.) $27.16
  • Previous close(U.S.) $27.15
  • High(U.S.) $27.25
  • Low(U.S.) $26.89
  • Bid / Ask(U.S.) $27.01 / (U.S.) $27.03
  • YTD % change-6.60%
  • Volume43,224
  • Average volume (10-day)271,091
  • Average volume (1-month)222,087
  • Average volume (3-month)284,324
  • 52-week range(U.S.) $19.21 to (U.S.) $29.38
  • Beta0.49
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward319.41×
  • Forward PEG14.20×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.21
Updated March 30 11:53 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.95%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue64413147
Total other revenue--------
Total revenue64413147
Gross profit42241626
Total cost of revenue21171620
Total operating expense51514149
Selling / general / administrative18171517
Research & development91289
Depreciation / amortization2222
Interest expense (income), net operating--------
Unusual expense (income)04----
Other operating expenses, total--------
Operating income13-10-10-2
Interest income (expense), net non-operating------0
Gain (loss) on sale of assets--------
Other--------
Income before tax12-10-10-2
Income after tax7-6-7-2
Income tax, total5-5-3-1
Net income7-6-7-2
Total adjustments to net income--------
Net income before extra. items7-6-7-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items7-6-7-2
Inc. avail. to common incl. extra. items7-6-7-2
Diluted net income7-6-7-2
Dilution adjustment----00
Diluted weighted average shares35343434
Diluted EPS excluding extraordinary itemsvalue per share0.20-0.17-0.20-0.04
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.20-0.10-0.20-0.04